Clinical Study
Efficacy of Goshajinkigan for Oxaliplatin-Induced Peripheral Neuropathy in Colorectal Cancer Patients
Table 2
Effectiveness of Goshajinkigan for treating peripheral neuropathy during oxaliplatin-based treatments for colorectal cancer.
| ā | GJG = 29 | Non-GJG = 44 | |
| Effect on peripheral neuropathy | Curative 1/29, 3.4% | Curative 2/44, 4.5% |
*vs.**ā P = 0.04 | Effective 6/29, 20.7% | Effective 7/44, 15.9% | Stabilizing 20/29, 69.0% | Stabilizing 20/44, 45.5% | Deleterious 2/29, 6.9%* | Deleterious 15/44, 34.1%** |
|
|
GJG: Goshajinkigan; : value.
|